By Ana Espino | Published on June 26, 2026 | 4 min read
Long overshadowed by other arboviral diseases such as
dengue, chikungunya, and Zika, Oropouche virus (OROV) is now attracting
increasing attention from public health authorities. Responsible for recurrent
outbreaks across Latin America, particularly in Brazil, this virus is primarily
transmitted by biting midges of the Culicoides genus. Until recently,
Oropouche infection was generally considered a mild, self-limiting febrile
illness.
However, several recent reports have raised a major concern:
the virus may be capable of crossing the placental barrier and affecting fetal
development. This hypothesis echoes the early observations made during the
emergence of the Zika virus. In light of these new findings, researchers
conducted a literature review to assess the current evidence regarding
Oropouche infection during pregnancy, its transmission pathways, and its
potential perinatal consequences.
Read next : Pregnancy
and Malaria : A High-Risk Combination
Growing Evidence for Mother-to-Child Transmission
The authors analyzed data from clinical studies, case
series, surveillance reports, and scientific publications focusing on Oropouche
infection during pregnancy. Their review identified several documented cases of
vertical transmission, confirmed through the detection of viral genetic
material in the placenta, amniotic fluid, umbilical cord blood, and even fetal
tissues.
The most concerning observations involve fetal outcomes. To
date, several cases of intrauterine fetal death have been associated
with maternal Oropouche virus infection. Other pregnancies have been
complicated by the development of congenital abnormalities, including microcephaly,
ventriculomegaly, corpus callosum abnormalities, cerebral atrophy, posterior
fossa malformations, and arthrogryposis.
The authors emphasize that these abnormalities predominantly
affect the central nervous system, suggesting a degree of neurotropism
comparable to that observed with other teratogenic arboviruses.
The analysis also suggests that infections occurring during
the first trimester of pregnancy may carry the highest risk of severe
complications, corresponding to critical stages of organogenesis. However,
adverse outcomes have also been reported following infections acquired later in
pregnancy.
Researchers further note that diagnosis remains challenging.
Symptoms—including fever, headache, muscle and joint pain, nausea, and
vomiting—closely resemble those caused by many other arboviral infections
circulating in the same regions. Laboratory confirmation relies primarily on RT-PCR
during the acute phase, followed by serological testing at later stages.
Read next : Zika:
A Latent Threat or a Past Danger?
Toward Recognition of a Congenital Oropouche Syndrome?
This review highlights the emergence of a previously
underrecognized risk associated with Oropouche virus infection. Current
evidence suggests that vertical transmission is possible and may lead to severe
fetal complications, particularly involving the nervous system.
However, the authors caution that knowledge remains limited.
Most available evidence comes from isolated cases and small observational
series, making it difficult to accurately estimate the frequency of
complications or establish a definitive causal relationship. The precise
mechanisms of placental transmission and the long-term neurodevelopmental
consequences for exposed children also remain poorly understood.
Despite these uncertainties, the findings support increased
vigilance in regions affected by Oropouche outbreaks. The authors advocate for
the inclusion of Oropouche virus in the differential diagnosis of febrile
illnesses during pregnancy, enhanced maternal-fetal surveillance, and the
implementation of large-scale prospective studies.
As occurred following the Zika epidemic, such research could
help characterize a potential congenital Oropouche syndrome and guide
the development of appropriate prevention and management strategies for
pregnant women at risk of exposure.
About the author – Ana Espino
PhD in Immunology, specialized in Virology
As a scientific writer, Ana is passionate about bridging the gap between research and real-world impact. With expertise in immunology, virology, oncology, and clinical studies, she makes complex science clear and accessible. Her mission: to accelerate knowledge sharing and empower evidence-based decisions. 
